Risks and benefits of phase 1 clinical trial participation.

about

Screening and analysis of breast cancer genes regulated by the human mammary microenvironment in a humanized mouse model Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery.

P2860

Q30008793-08CF5E24-A346-45C1-A73C-5313F2700AA2 Q33688966-9222EA84-B7F9-4C04-8307-59B605E8DA1D

P2860

Risks and benefits of phase 1 clinical trial participation.

Item

http://www.wikidata.org/entity/Q38222465

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Risks and benefits of phase 1 clinical trial participation.

@en

type

Item

label

Risks and benefits of phase 1 clinical trial participation.

@en

prefLabel

Risks and benefits of phase 1 clinical trial participation.

@en

P1476

Risks and benefits of phase 1 clinical trial participation

@en

P2093

Danny Nguyen

http://www.w3.org/2001/XMLSchema#string

P2860

Use of randomisation in the Medical Research Council's clinical trial of streptomycin in pulmonary tuberculosis in the 1940s.

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias

Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.

Survival of 1,181 patients in a phase I clinic: the MD Anderson Clinical Center for targeted therapy experience

Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act.

Clinical trials in advanced stage lung cancer: a survey of patients' opinion about their treatment

Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience.

Risks and benefits associated with novel phase 1 oncology trial designs.

P304

193-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107327481402100303

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amit Mahipal

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24955702

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

Risks and benefits of phase 1 clinical trial participation.

about

P2860

P2860

Risks and benefits of phase 1 clinical trial participation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921